|
|
MARKETS
RECOMMENDATION:
Glenmark Pharma (Rs 234.65): Buy
We recommend a buy in Glenmark Pharmaceuticals from a short-term perspective. It is apparent from the charts of Glenmark Pharmaceuticals that it has been trending up since its 52-week low of Rs 119 recorded on February 5. Since then, the ...
RECOMMENDATION:
Day Trading Guide
DLF has formed a spinning top candlestick pattern in the last trading session, indicating indecisiveness. Avoid trading in this counter for the session. Utilise rallies to sell ...
VENTURE CAPITAL:
QIP round 2 likely to see lukewarm response
High valuations, concentration of realty cos may sag interest. Mumbai, June 24 Investor interest may remain rather subdued for the second round of Qualified Institutional Placements (QIP), which has been announced, said ...
INVESTMENTS:
Anchor investor
Make no mistake, an anchor investor, who is all set to be unleashed by SEBI into the dormant primary market to rev it up, is not an angel investor. An angel investor is a benevolent person with deep pockets and capacity to play the role of ...
INVESTMENTS:
Retail investors stay longer than biggies in equity funds
Only 18% of institutions remain in equity funds beyond 2 years: AMFI study. BL Research Bureau Retail investors take a longer-term view of mutual fund schemes than high net worth individuals (HNIs), FIIs, banks or financial institutions, ...
FOREIGN INSTITUTIONAL INVESTORS:
SEBI ban on Jermyn Cap till Nov 2010
Mumbai, June 24 SEBI has set November 2010 as the expiry date of its order restraining Jermyn Capital, a Dubai-based FII sub-account, from dealing in the securities ...
STOCKS:
Forceites’ online stock analysis tool launched
Mumbai, June 24 Forceites has announced the launch of an online stock analysis application that will generate calls for customers on stock price movements. The product, called Interday Trading Signals, is available through Vantagetrade.com, ...
DERIVATIVES MARKETS:
Open interest high for Nifty 3800 put, 4700 call in July
Chennai, June 24 Turnover on Wednesday dipped marginally to Rs 82,940.03 crore in the F&O segment as compared with Tuesday’s figure of Rs ...
Columnists:
•
Harish Bijoor
•
Ramanujam Sridhar
•
S Ramesh Kumar
•
Radhika Chada
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
|
|
RSS Feeds